Analyst Price Targets — AMWL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 12:14 pm | David Grossman | Stifel Nicolaus | $5.00 | $4.43 | TheFly | Amwell price target lowered to $5 from $6 at Stifel |
| November 5, 2025 12:31 pm | — | Stifel Nicolaus | $6.00 | $4.71 | TheFly | Amwell price target lowered to $6 from $8 at Stifel |
| January 6, 2023 8:45 am | — | Morgan Stanley | $87.09 | $46.16 | Benzinga | Morgan Stanley Maintains Overweight on American Well, Lowers Price Target to $6 |
| September 7, 2022 4:36 am | Jessica Tassan | Piper Sandler | $90.72 | $78.74 | TheFly | Amwell price target lowered to $5 from $6 at Piper Sandler |
| December 17, 2021 12:00 am | Ricky Goldwasser | Morgan Stanley | $163.30 | $116.84 | Investing | Morgan Stanley Stick to Their Buy Rating for American Well |
| December 1, 2021 12:00 am | Glen Santangelo | Jefferies | $108.86 | $112.85 | TheFly | Amwell initiated with a Hold at Jefferies |
| November 12, 2021 12:00 am | Kevin Caliendo | UBS | $181.63 | $157.13 | StreetInsider | American Well Corp. (AMWL) PT Lowered to $10 at UBS |
| September 14, 2021 12:00 am | Steven Halper | Cantor Fitzgerald | $272.33 | $187.80 | TheFly | Amwell initiated with an Overweight at Cantor Fitzgerald |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for AMWL

Hims & Hers and Amwell are taking different paths in telehealth, but which stock offers the stronger opportunity today? Let's dive in.

BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the TD Cowen 46th Annual Health Care Conference, taking place in Boston on March 3, including a fireside chat at 3:10 p.m. ET. An audio webcast of the fireside chat will be…

American Well (NYSE: AMWL - Get Free Report) and Careview Communications (OTCMKTS:CRVW - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends. Profitability This table compares American Well and Careview

BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announced that on February 18, Amwell made a grant of RSUs of 61,559 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. The RSUs will vest as follows, subject…

American Well (AMWL) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMWL.
U.S. House Trading
No House trades found for AMWL.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
